Your session is about to expire
← Back to Search
Inspiratory Muscle Training for Orthopedic Surgery Recovery
N/A
Recruiting
Led By Barbara Smith, PhD
Research Sponsored by University of Florida
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
History of smoking-related lung disease
Age 18 or older
Must not have
Preoperative dependence on continuous supplemental oxygen
Severe obstructive pulmonary disease (Classification of Global Initiative for Chronic Obstructive Lung Disease (GOLD) 3 or higher, indicating FEV1<50% predicted)
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24-hours post-op.
Awards & highlights
No Placebo-Only Group
Summary
This trialwill evaluate if pre-surgery breathing exercises can help improve breathing function and recovery after orthopedic surgery. #medicalresearch
Who is the study for?
This trial is for adults over 18 who have smoked or currently smoke, may have lung disease, and are undergoing orthopedic surgery. They should be able to do breathing exercises and report any issues like pain. People with severe lung obstruction, very poor health status, recent serious infections, oxygen dependency, certain neurological conditions or those in pulmonary rehab can't join.
What is being tested?
The study tests if pre-surgery breathing exercises (acute or daily) can improve recovery compared to standard care in patients having joint surgery. It aims to see whether these exercises before surgery help strengthen the respiratory muscles and enhance postoperative breathing function.
What are the potential side effects?
Potential side effects from inspiratory muscle training could include discomfort or fatigue during the exercises. However, specific side effects will depend on individual tolerance and condition.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I have lung problems due to smoking.
Select...
I am 18 years old or older.
Select...
My surgery is expected to last more than 30 minutes.
Exclusion Criteria
You may be eligible for the trial if you check “No” for criteria below:Select...
I need to use extra oxygen all the time.
Select...
I have severe lung disease with less than half the normal airflow.
Select...
My health is severely limited by my illness.
Select...
I do not have an infectious disease that requires isolation.
Select...
I need a breathing machine during the day (nighttime CPAP is okay).
Select...
I have been diagnosed with a neurological condition like MS, ALS, Parkinson's, or have had a stroke.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 24-hours post-op.
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24-hours post-op.
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Forced vital capacity (FVC)
Maximal Inspiratory Pressure (MIP)
Secondary study objectives
Post operative pulmonary complications
Awards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
3Treatment groups
Experimental Treatment
Active Control
Group I: Daily IMT (dIMT)Experimental Treatment1 Intervention
IMT (inspiratory muscle training) is a treatment strategy aimed to strengthen the muscles of inspiration, the diaphragm and external intercostals, by increasing their force-generating capacity. Participants in the dIMT (daily IMT) will complete daily inspiratory training exercises 2-4 weeks prior to surgery. A pressure threshold training device containing an adjustable-tension spring to provide resistance during inspiration will be used. Subjects will complete 5 sets of 5 maximal volume and speed breaths daily at a pressure 70% of MIP and will rest 1 minute between sets. They will be asked to keep a log to track their sessions to evaluate compliance with the exercise regimen.
Group II: Standard of Care (SOC)Active Control1 Intervention
The SOC group will receive the usual surgical standard of care only.
Group III: Acute IMT (aIMT)Active Control1 Intervention
Patients in the aIMT (acute IMT) experimental group will complete a single session of IMT guided by a physical therapist within 30 minutes of anesthesia induction in addition to standard of care. The adjustable pressure threshold training device to provide resistance during inspiration will be used. Subjects will complete 5 sets of 5 maximal volume and speed breaths, and rest 1 minute between sets. The training intensity will be set at 70% of MIP.
Find a Location
Who is running the clinical trial?
National Institute on Aging (NIA)NIH
1,805 Previous Clinical Trials
28,194,821 Total Patients Enrolled
University of FloridaLead Sponsor
1,409 Previous Clinical Trials
767,187 Total Patients Enrolled
Barbara Smith, PhDPrincipal InvestigatorUniversity of Florida, College of Public Health and Health Professions - Gainesville
Stefan Braunecker, MDPrincipal InvestigatorUniversity of Florida College of Medicine-Jacksonville
2 Previous Clinical Trials
290 Total Patients Enrolled
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- I have lung problems due to smoking.I need to use extra oxygen all the time.I have had pneumonia or a lung infection in the last two weeks that needed steroids or antibiotics.I have severe lung disease with less than half the normal airflow.My health is severely limited by my illness.I am enrolled in a lung rehab program.You have used tobacco or nicotine-containing products in the past or currently.I have risk factors for lung problems after surgery, such as smoking history or lung disease.I do not have an infectious disease that requires isolation.I am 18 years old or older.I need a breathing machine during the day (nighttime CPAP is okay).I have been diagnosed with a neurological condition like MS, ALS, Parkinson's, or have had a stroke.My surgery is expected to last more than 30 minutes.
Research Study Groups:
This trial has the following groups:- Group 1: Standard of Care (SOC)
- Group 2: Acute IMT (aIMT)
- Group 3: Daily IMT (dIMT)
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.